Clinuvel Pharmaceuticals Stock
Clinuvel Pharmaceuticals Stock
There is an upward development for Clinuvel Pharmaceuticals compared to yesterday, with an increase of €0.17 (1.820%).
Our community identified positive and negative aspects for Clinuvel Pharmaceuticals stock for the coming years. 1 users see the criterium "Valuation (undervalued/overvalued)" as a plus for the Clinuvel Pharmaceuticals stock. On the other hand our users think that "Customer and product portfolio" could be a problem in the future.
Pros and Cons of Clinuvel Pharmaceuticals in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Clinuvel Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Clinuvel Pharmaceuticals | 1.820% | -0.656% | -2.312% | -28.267% | -7.239% | -50.355% | -39.271% |
| Syros Pharmaceuticals Inc. | 2.470% | -2.490% | 9.302% | 72.794% | -28.788% | -90.600% | - |
| Pharma Mar S.A. | 4.750% | 11.181% | 12.367% | -16.172% | -24.136% | -66.730% | - |
| Starpharma Holdings Ltd. | -9.450% | -13.605% | -9.929% | -77.641% | -32.804% | -94.330% | -91.962% |
